Ma devo essere sincera: dopo la raccomandazione del dottore di fare la vitrectomia e' estremamente difficile essere felice! Ci penso da tre giorni e sono in stato simile alla depressione. Vedo le mie mosche molto' piu' di prima perche' ogni minuto cerco di convincermi che non sono cosi' grave e finisco per fissarmi!
credo che la cosa migliore e più rapida per toglierti dall'inghippo sia prendere il telefono, chiamare il buon Crevatin (che comunque sono certo ci sta seguendo) e spiegargli il tuo stato, chiedendogli perchè ti ha invitato alla vitreo senza che tu ne sentissi il bisogno
Se poi ti dirà "no guardi avevo capito che per lei era un problema grave" ti sarai tolta lo spino dalla carne....
POMODORINO, SE HAI TUTTI QUESTI DUBBI VAI DA UN ALTRO!!!
NON PUOI SOPPESARE LE PAROLE E POI RIMUGINARCI SOPRA IN QUESTO MODO.
TANTE VOLTE I MEDICI NON CAPISCONO CHE MOLTE PERSONE PENDONO DALLE LORO LABBRA PERCHE' ANSIOSE, IN SITUAZIONE GIA' DI SVANTAGGIO RISPETTO A LORO E FIDUCIOSE, E OGNI LORO PAROLA PUO' ESSERE DETERMINANTE.
ORA IO AVREI GIA' TIRATO DRITTO E PENSATO CHE STO' OCULISTA L'HA SPARATA COSI' PER DIRE, MA SE NON SEI SICURA VAI DA UN ALTRO E CHIEDI SPIEGAZIONI
IO HO IL VITREO CHE E' UNA M..... MA NESSUN OCULISTA MI HA CONSIGLIATO LA VITRECTOMIA.
TROPPO ZELO NEI DOTTORI A VOLTE E' LA SOLA CAUSA DEI NOSTRI MALESSERI.
STAI TRANQUILLA NON SEI L'UNICA CON IL VITREO CHE E' UNO SCHIFO MA LA VITRECTOMIA E' UNA ALTRA COSA..
io ribadisco il mio consiglio. Andrei a trovare il prof siravo. Perchè lui ha detto chiaramente ad un utente di questo forum che
1) fa un sacco di vitrectomie.
2) non gli avrebbe mai fatto la vitrectomia anche dietro profumatissimo compenso.
questo vuol dire che valuta davvero se è necessaria o no, senza farsi inquinare da altri ragionamenti, anche economici.
In più gode fama di essere uno dei migliori professionisti italiani.
qui non stiamo parlando di decidere se ritoccarsi le tette o no! Qui stiamo parlando dei nostri occhi e di una decisone irreversibile e fondamentale. Roma non è poi cosi lontana da Pisa.
Thank you for your enquiry of June 25th, which was transmitted to us.
Vitreous floaters are a common problem also among our patients. Some of them describe less annoyance by these floaters during and after our treatments with iod-iontophoresis (during this therapy, the eye is “bathed” in special bowls in which the iodine saline solution is charged with weak galvanised electricity. The iodine particles can thus reach into and take effect deep in the eye), due to better blood circulation and metabolism in the posterior eye.
Total removal cannot be expected, but our patients notice these floaters more rarely.
The best results can be expected after 18 treatments (3 weeks), but it would also be possible to make our treatments for 1 week (6 treatments) or 2 weeks (12 treatments), but at first you need an appointment at the ophtalmologist in our eye-ambulance, and after special eye examination by the doctor, suitable therapies will be prescribed for you.
The costs of one week (includes examination by the doctor and 6 treatments for one week) are at about 146, -- Euro.
We hope, our information was adequate and helpful. If you need more information, please contact us again.
i.A. Pillesberger Petra
Orthoptistin & LowVision-Trainerin
Ambulatorium für Augenheilkunde
ma guarda Pomo non bisogna avere troppa paura degli interventi.
se sono necessari significa che è peggio non farli.
in ogni caso sentire sempre la maggior parte di opinioni mediche possibili...
poi guarda il nome vitrectomia fa paura ma ci sono interventi molto più invasivi e che invece fanno meno paura quindi in ogni caso non pensarci troppo , se riesci...
in merito agli interventi di chirurgia estetica che qualcuno ha citato i rischi sono sicuramente maggiori rispetto a quelli della vitrectomia.
Amino acids and iodine iontophoresis treatment of vitreous opacities in the Evaluation of denaturation
April 21, 2008
Abstract Objective To analyze the amino acids and iodine iontophoresis in the treatment of vitreous opacities in clinical variability. Methods will be no trauma history of 300 cases of patients with vitreous opacities degeneration (350 eyes) were randomly divided into treatment group 150 patients (175 eyes) and control group 150 patients (175 eyes). Treatment group with amino acids and iontophoresis apparatus to iodine ions to the treatment, control group with amino acids and iodine topical eye treatment of eye drops. Results of amino acids and iodine iontophoresis effect of treatment group and control group difference was significant. Conclusion amino acids and iodine iontophoresis treatment of vitreous body degeneration cloudy with good effect.
Key words amino acids and iodine iontophoresis; vitreous degeneration opacity; treatment
Cloudy vitreous degeneration of people over the age of 45 is a relatively common eye disease. Amino acids and iodine used in clinical drug treatment, amino acids and iodine in the eye and the whole system using porcine thyroid hydrolysis by trypsin and extraction of fungi made of chemical and biological agents, with machine iodine and glutamic acid, cystine, glycine, histidine days , aspartate, lysine and other 18 kinds of amino acids, peptides, nucleotides and various trace elements. Amino acids and iodine iontophoresis treatment of degenerative vitreous opacities can improve eye blood circulation and metabolism, and promote absorption of turbid, and promote regeneration of tissue repair and improve visual function, and thus to reduce or eliminate the effect of vitreous opacities degeneration . These are as follows.
1 Materials and Methods
1.1 General data collection in January 2001 ~ July 2006 out-patient treatment has been 300 cases of vitreous opacities degeneration, 98 cases were male and female 202 cases, aged 45 to 80 years, average 62.5 years old. One with the disease: high myopia 98 eyes, 30 eyes with cataract, macular lesions seven old, retinal flash 54. 300 cases of patients had no history of trauma, B Chao said: glass body strip, point-like opacity, retinal detachment phenomenon no. Dilate fundus examination: vitreous degeneration cloudy forms: point-like, muddy turbidity 125, flocculent turbidity 107, lump turbid 105, posterior vitreous detachment in 13 eyes cloudy ring. Time of onset: <1> 6 months 153.
1.2 Methods Patients were randomly divided into two groups, treatment group 150 patients (175 eyes) and control group 150 patients (175 eyes). Treatment group iontophoresis device, eye pad method, patients taking seats, instrument frames into place two electrodes 4cm × 5cm gauze, placed in the appropriate Department of saline copper cotton balls, cotton balls on a trickle in about 0.5ml amino acids and iodine eye drops, and conjunctiva of the eye drops eyes closed point of amino acids and shy, then put on frames, so that copper, cotton and eyelids full access, closely aligns, frames with fixed occipital; another highly placed in the palm (normal saline wet cotton ball rubbed the palm) to select positive. Typically the current 0.3 ~ 0.5mA, treatment 15min, daily treatment of 1, 15 days a course of treatment for 2 courses. Control group with amino acids and iodine topical eye drops eyes, each time 2 drops 4 times a day, 15 days a course of treatment for 2 courses.
1.3 Therapy Clinical symptoms and examination findings, divided into cured, markedly effective, effective, ineffective four levels. Cure: immediate shadow disappeared, retinal flash disappeared, visual acuity improvement, to dilate fundus examination punctate, sand-like opacities are absorbed removal; markedly: the immediate shadow disappeared, retinal flash disappeared, visual acuity was no increase; valid: dot sight , reticular shadows disappear, lump narrow pale shadow, to dilate narrow fundus examination with mass chaos, pale; invalid: no improvement of symptoms.
Two groups were all in the two treatment effects were compared after the show: amino acids and iodine iontophoresis treatment of 150 cases (175), 49 cured, the cure rate of 28%; markedly 70, showed 40% efficiency; effective 35 eyes, there is efficiency of 20%; invalid 21, no 12% efficiency; total efficiency of 88%. The control group 150 patients (175 eyes), 14 eyes were cured, the cure rate of 8%; markedly 21, was 12% efficiency; effective 49, efficiency 28%; invalid 91, no efficiency of 52%; total efficiency 48% . The efficiency of the two groups compared, P <0.05, the difference was statistically significant (see Table 1). Table 12 courses of treatment after the situation is more cloudy vitreous degeneration eyes (a little) 3 discussions
Cloudy vitreous degeneration in people over 45 years of age a higher prevalence of three common types: vitreous degeneration in senile opacity, myopic degeneration vitreous opacities, posterior vitreous detachment. Transparent vitreous gel, the gel structure consists of collagen fibers and hyaluronic acid composition of macromolecules during filling. As we age, the vitreous body hyaluronic acid depolymerization, precipitation combined with water, produces a small liquefied cavity. Also composed of fine fibers of collagen scaffolds degeneration, condensed together to form turbid body. In addition to denaturation and aggregation of collagen fibers, the primary vitreous in the vitreous of residual cells in the artery wall can be formed in the liquefied vitreous body floating in the haze. When the myopic haze moving body axis, was outside the light projected onto the macular area, were facing a floating fine point, hair, or spider. Such as the eyes in patients with sudden large turbidity or associated with flash, indicating vitreous detachment may occur. Sudden onset of posterior vitreous detachment, floaters and flashing a sense of its main symptoms. The reason may lead to flash out of the posterior vitreous cortex, stretch stimulated the retina associated with it; it may be out of the cortex in eye movement, the impact of the retina caused by . Variability in patients with vitreous opacities obvious symptoms, so as soon as possible to help patients get rid of discomfort so as to improve the quality of life is particularly important. Amino acids and iodine iontophoresis treatment of degenerative vitreous opacities and the effect of significantly faster, its principles: first, the ions into the blood-aqueous barrier from the impact of drugs can be imported directly by the eye cornea; Second, using the drug ion DC through the skin or mucous membrane into the eye, than the local effect of eye drops eye drops several times bigger; Third, the dual role of DC and drugs, increase the corresponding segments of the blood circulation, improve the local metabolism of oxygen and nutrition to accelerate the pathological agents of chemical medium discharged; Fourth, amino acids and iodine in iodide of drug absorption can promote inflammation, soften the fibrous tissue, release adhesions role. Amino acids and iodine iontophoresis in the treatment of vitreous opacities in the process of degeneration, we must first rule out vitreous hemorrhage, and other eye inflammation, cloudy vitreous degeneration is diagnosed before treatment. In addition, short duration, spotty, muddy sand-like effects in patients with good, accompanied with cataract, vitreous detachment, or macular lesions, treatment was stopped. The larger clumps of vitreous degeneration machine compounds can improve symptoms in patients with opacity, reduced opacity, fundus examination, pale, but not completely. Degeneration of the vitreous opacity in this group 150 patients (175 eyes) with amino acids and iodine iontophoresis therapy has been observed statistics, the total effective rate was 88%, and the control group and 48% difference was significant. Amino acids and clinical validation of accelerating the introduction of iodine ions discharged pathological agents of chemical media role in promoting the vitreous dot, kind of muddy sediment removal, speed up the floc turbid, muddy narrow pale with mass, thus improving symptoms of patients, does not relieve the suffering of patients. Shows that amino acids and iodine iontophoresis treatment of vitreous opacities variability than simple amino acids and iodine partial eye eye drops with the exact significant effect.
YANG Pei-zeng 1, Jia-Qi Chen, Jian Ge, et al. Ophthalmology Basic and Clinical. Beijing: People's Medical Publishing House, 2006,368.
2 Li Fengming. Journal of Ophthalmology, 2nd ed. Beijing: People's Medical Publishing House ,2005,2245-2246.
Tutti i fusi orari sono GMT + 1 ora Vai a pagina 1, 2, 3, 4, 5, 6Successivo
Pagina 1 di 6
Non puoi inserire nuovi Topic in questo forum Non puoi rispondere ai Topic in questo forum Non puoi modificare i tuoi messaggi in questo forum Non puoi cancellare i tuoi messaggi in questo forum Non puoi votare nei sondaggi in questo forum